About GlySens
GlySens is a company based in San Diego (United States) founded in 1997.. GlySens has raised $47 million across 9 funding rounds from investors including HHS, McNair Interests and Fayez Sarofim. The company has 29 employees as of December 31, 2022. GlySens offers products and services including Breakfast Menu, Salads, and Coneys. GlySens operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
- Headquarter San Diego, United States
- Employees 29 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
- Legal Name Glysens Incorporated
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$47 M (USD)
in 9 rounds
-
Latest Funding Round
$15 M (USD), Unspecified
Jun 12, 2020
-
Investors
HHS
& 4 more
-
Employee Count
29
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GlySens
GlySens offers a comprehensive portfolio of products and services, including Breakfast Menu, Salads, and Coneys. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides various breakfast items for morning dining
Offers fresh salad options as healthy meal choices
Specializes in coney-style hot dogs and related items
Unlock access to complete
Funding Insights of GlySens
GlySens has successfully raised a total of $47M across 9 strategic funding rounds. The most recent funding activity was a Unspecified round of $15 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Unspecified — $15.0M
-
First Round
First Round
(01 Jun 2007)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Unspecified - GlySens | Valuation | McNair , Fayez Sarofim |
|
| Dec, 2015 | Amount | Unspecified - GlySens | Valuation |
investors |
|
| Jan, 2015 | Amount | Unspecified - GlySens | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GlySens
GlySens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, McNair Interests and Fayez Sarofim. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are offered by McNair Interests in Houston.
|
Founded Year | Domain | Location | |
|
Global private equity investments are managed from Houston.
|
Founded Year | Domain | Location | |
|
Research and health information on diabetes and kidney diseases are provided by NIDDK.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GlySens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GlySens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glysens Comparisons
Competitors of GlySens
GlySens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Senseonics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
|
| domain | founded_year | HQ Location |
Gamified apps for diabetes management and therapy are provided.
|
|
| domain | founded_year | HQ Location |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| domain | founded_year | HQ Location |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about GlySens
When was GlySens founded?
GlySens was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Where is GlySens located?
GlySens is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of GlySens?
William Markle is the current CEO of GlySens.
Is GlySens a funded company?
GlySens is a funded company, having raised a total of $47M across 9 funding rounds to date. The company's 1st funding round was a Unspecified of $12M, raised on Jun 01, 2007.
How many employees does GlySens have?
As of Dec 31, 2022, the latest employee count at GlySens is 29.
What does GlySens do?
GlySens Incorporated was founded in 1997 in San Diego, United States, within the biomedical technology sector. Implantable sensors for continuous glucose monitoring are produced, offering real-time blood glucose readings, historical data charts, adjustable alerts for hypo- and hyperglycemic events, and onboard storage. Wireless connections to external receivers are enabled, with preclinical trials indicating sensor lifetimes of up to 18 months. Operations focus on diabetes management solutions.
Who are the top competitors of GlySens?
GlySens's top competitors include Dexcom, Senseonics and One Drop.
What products or services does GlySens offer?
GlySens offers Breakfast Menu, Salads, and Coneys.
Who are GlySens's investors?
GlySens has 5 investors. Key investors include HHS, McNair Interests, Fayez Sarofim, National Institute of Diabetes and Digestive and Kidney Diseases, and West Health.